MARC L PETERS-GOLDEN, MD
Osteopathic Medicine in Ann Arbor, MI
License number
Michigan 4301047562
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301047562
Category
Osteopathic Medicine
Type
Pulmonary Disease
Address
Address
1500 Floor Taubman Ctr, Ann Arbor, MI 48109
Phone
(734) 647-9342
(734) 936-2047
(734) 936-2047
Personal information
See more information about MARC L PETERS-GOLDEN at radaris.comName
Address
Phone
565 Green Rd, Ann Arbor, MI 48105
Professional information
Dr. Marc L Peters-Golden, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Critical Care Medicine, Pulmonology
Address:
University Michigan Hospital PCC
1500 E Medical Center Dr, Ann Arbor 48109
(734) 763-2540 (Phone)
1500 E Medical Center Dr, Ann Arbor 48109
(734) 763-2540 (Phone)
Certifications:
Critical Care Medicine, 1987, Internal Medicine, 1981, Pulmonary Disease, 1984
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
University Michigan Hospital PCC
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
Duke University School Of Medicine
Graduated: 1978
Tufts New England Med Center
Graduated: 1979
Graduated: 1981
Johns Hopkins Hospital
Graduated: 1984
Duke University School Of Medicine
Graduated: 1978
Tufts New England Med Center
Graduated: 1979
Graduated: 1981
Johns Hopkins Hospital
Graduated: 1984
Marc L Peters-Golden, Ann Arbor MI
Specialties:
Pulmonologist
Address:
1150 W Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
Duke University, School of Medicine - Doctor of Medicine
Johns Hopkins Hospital - Fellowship - Pulmonary Disease (Internal Medicine)
Tufts Medical Center - Residency - Internal Medicine
Johns Hopkins Hospital - Fellowship - Pulmonary Disease (Internal Medicine)
Tufts Medical Center - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Pulmonary Disease (Internal Medicine)
Administration Of Products Of The 5-Lipoxygenase Metabolic Pathway To Enhance Antimicrobial Defense
US Patent:
7696148, Apr 13, 2010
Filed:
Mar 3, 1999
Appl. No.:
09/291656
Inventors:
Marc Peters-Golden - Ann Arbor MI, US
Theodore Standiford - Ann Arbor MI, US
Theodore Standiford - Ann Arbor MI, US
Assignee:
Board of Trustees of Michigan State University - East Lansing MI
International Classification:
C07K 14/00
US Classification:
514 2, 530300, 530350
Abstract:
The use of leukotrienes and other products of the 5-lipoxygenase pathway to enhance bacterial defense and treat infections is described. The products are especially useful when administered to the lungs for the treatment of pneumonia and other lower respiratory tract infections. The products may be administered for treatment or prophylactic purposes and may be administered concomitantly with antibiotics to combat infection.
Administration Of Products Of The 5-Lipoxygenase Metabolic Pathway To Enhance Antimicrobial Defense
US Patent:
2005026, Dec 1, 2005
Filed:
Jan 19, 2005
Appl. No.:
11/038883
Inventors:
Marc Peters-Golden - Ann Arbor MI, US
Theodore Standiford - Ann Arbor MI, US
Theodore Standiford - Ann Arbor MI, US
International Classification:
A61K031/202
US Classification:
514560000
Abstract:
The use of leukotrienes and other products of the 5-lipoxygenase pathway to enhance bacterial defense and treat infections is described. The products are especially useful when administered to the lungs for the treatment of pneumonia and other lower respiratory tract infections. The products may be administered for treatment or prophylactic purposes and may be administered concomitantly with antibiotics to combat infection.
Administration Of Products Of The 5-Lipoxygenase Metabolic Pathway To Enhance Antimicrobial Defense
US Patent:
5909734, Jun 8, 1999
Filed:
Dec 3, 1996
Appl. No.:
8/757136
Inventors:
Marc Peters-Golden - Ann Arbor MI
Theodore Standiford - Ann Arbor MI
Theodore Standiford - Ann Arbor MI
Assignee:
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61B 1900, A61K 704
US Classification:
128898
Abstract:
The use of leukotrienes and other products of the 5-lipoxygenase pathway to enhance bacterial defense and treat infections is described. The products are especially useful when administered to the lungs for the treatment of pneumonia and other lower respiratory tract infections. The products may be administered for treatment or prophylactic purposes and may be administered concomitantly with antibiotics to combat infection.